Schizophrenia Trial, Recruiting (NCT06640803)

Schizophrenia Trial, Recruiting NCT06640803 Sponsor: University of California, Davis Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06640803 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been assessed as being at high risk of developing psychosis, based on a specific screening tool called the mini-SIPS
You are between 12 and 25 years old
You are currently receiving mental health care at one of six specific community mental health clinics involved in the study
You are eligible for Sacramento County Medi-Cal (confirm with trial site)
You are able to give your own consent to take part in the study (for younger participants, this may involve a parent or guardian — confirm with trial site)

Who may not be able to join:

You have an intellectual disability, meaning your IQ has been measured as below 70
You currently need a more intensive level of mental health care urgently, such as inpatient or crisis services

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 916-734-7875

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06640803

Sponsor: University of California, Davis

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 916-734-7875

More information: https://clinicaltrials.gov/study/NCT06640803

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been assessed as being at high risk of developing psychosis, based on a specific screening tool called the mini-SIPS
You are between 12 and 25 years old
You are currently receiving mental health care at one of six specific community mental health clinics involved in the study
You are eligible for Sacramento County Medi-Cal (confirm with trial site)
You are able to give your own consent to take part in the study (for younger participants, this may involve a parent or guardian — confirm with trial site)

Who may not be able to join:

You have an intellectual disability, meaning your IQ has been measured as below 70
You currently need a more intensive level of mental health care urgently, such as inpatient or crisis services

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Davis

Registry

ClinicalTrials.gov

Start date

20 March 2023

Est. completion

1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility: The number of youth at clinical high risk for psychosis enrolled in stepped care over the course of the intervention.; Acceptability: Proportion of enrolled youths who move into each step of stepped-care; Reach: Universal screening outcomes; Reach: Number of community clinicians trained in specialized stepped care; Effectiveness: Number of youth who meet criteria for a clinical high risk for psychosis (CHRp) syndrome at each step of the intervention.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov